Skip to search.
 FTSE 100 Up 0.31%

MannKind Corp. (MNKD)

-NasdaqGM
0.79 Down 0.05(5.61%) 26 Aug 21:00
|After Hours: : 0.82 Up 0.03 (3.98%) 26 Aug 23:48
Prev Close:0.84
Open:0.84
Bid:0.77 x 200
Ask:0.89 x 1800
1y Target Est:0.15
Beta:2.39767
Earnings Date:7 Nov - 11 Nov (Est.)
Day's Range:0.77 - 0.85
52wk Range:0.64 - 4.07
Volume:6,143,482
Avg Vol (3m):3,303,070
Market Cap:376.99m
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MNKD at this time.

Comparison

Symbol% ChgMkt Cap
MNKDDown 5.61%376.99m
LLYUp 0.29%82.56b
GSKDown 0.43%105.85b
NVOUp 0.09%118.93b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.23
Quarterly EPS Est (Sep-16) :-0.05
Mean Recommendation*:3.8
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback